Lost in the technical debate over drug prices is a struggle to afford medications happening across the country.
Big Pharma
Posted inPolitics
Kathleen Rice’s Questionable Rationale for Voting Down Drug Pricing Reform
She says she voted against the measure because the reconciliation bill won’t become law.
Posted inTAP
Vaccine Update: Pfizer Sticks It to Uncle Sam
Today on TAP: The drug industry and global vaccine needs
Posted inPolitics
How Kathleen Rice Is Threatening the Biden Agenda
Rice and two other House Democrats oppose aggressive drug price reform, which provides the budget savings available to fuel spending in the Build Back Better Act.
Posted inHealth and Social Policy
House, Senate Spar Over Reducing Drug Prices
There’s overwhelming support among Democrats for finally allowing Medicare to negotiate with drug companies. But the details matter.
Posted inPolitics
A Devastating Week for This Country
Thoughts on a flooded country, a theocratic state, and a creaking democracy
Posted inCoronavirus
Why Pfizer’s Friends Want Biden to Intervene in Brazil
The pharma giant is trying to squash a bill that would expand vaccine access.
Posted inTAP
Biden’s Worldwide Vaccine Policy—Big Pharma Keeps Winning
Today on TAP: The disgraceful gap between the administration’s words and deeds
Posted inLaw and Justice
How Do You Solve a Problem Like the Sacklers?
Judges have grown accustomed to issuing get-out-of-litigation cards to corporate looters in bankruptcy court.
Posted inHealth and Social Policy
How Biden Can Reinvent Big Pharma
So it can’t buy off competitors to keep prices high